Just trying to get my head around the 4 endpoints (specifically communication) that didn't show statistical significance but caregiver & clinician scores for receptive and expressive communication showed improvement? Appreciate the more scientific minded here to add their learned inputs.
- Forums
- ASX - By Stock
- NEU
- Ann: P2 trial shows significant improvements in Phelan-McDermid
NEU
neuren pharmaceuticals limited
Add to My Watchlist
1.08%
!
$12.68

Ann: P2 trial shows significant improvements in Phelan-McDermid, page-32
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$12.68 |
Change
0.135(1.08%) |
Mkt cap ! $1.559B |
Open | High | Low | Value | Volume |
$12.61 | $12.68 | $12.61 | $15.89K | 1.26K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 430 | $12.55 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.76 | 986 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 387 | 12.480 |
1 | 50 | 12.470 |
1 | 500 | 12.450 |
1 | 219 | 12.430 |
1 | 500 | 12.420 |
Price($) | Vol. | No. |
---|---|---|
12.540 | 2 | 1 |
12.550 | 25 | 1 |
12.560 | 25 | 1 |
12.570 | 148 | 2 |
12.580 | 50 | 1 |
Last trade - 09.59am 25/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |